Navigation Links
ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin

Speculation that the Food and Drug Administration will give a nod for the generic version of Vancocin caused shares in ViroPharma to dip by about 33 percent. The rumors of the FDA's changed perspective // strengthened after Laura Alvey, a spokeswoman for the F.D.A said in an e-mail message that the agency had "recently revised the bioequivalence recommendations for oral vancomycin from a clinical trial with bioequivalence endpoints to an in vitro method involving dissolution testing."

Vancocin or vancomycin is used exclusively to treat hospital-acquired bacterial infections caused in the lower digestive tract by the bacterium Clostridium difficile. Basically, the FDA's changed stance means that a clinical trial for generic vancomycin might not be necessary if it dissolves at the same rate as Vancocin. ViroPharma has intimated that it has filed a petition to stay the action with the F.D.A and added that it would file many more petitions to support "vigorous opposition to any approach that does not require rigorous scientific methods to demonstrate a rate and extent of drug release to the site of action consistent with good medicine and science." But analysts at Infinium Capital feel that a generic version of Vancocin could be available by early 2008. "Previously, generic manufacturers may not have been interested in developing this therapeutic due to its low revenue potential; however, with the recent sales growth of 133 percent in 2005, Vancocin is now on the radar screen," an analyst at Infinium Capital, Bernadine Leung, said.
'"/>




Page: 1

Related medicine news :

1. Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail
2. Sun Pharma Allots Shares Upon Fccbs Conversion
3. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
4. FDA Moves In To Check Listeria
5. Genetic Test for Type II Diabetes Moves Closer
6. Inhaled Insulin Study Moves Ahead
7. Looking Towards More Effective Leukemia Treatment
8. Attitude Towards AIDS Patients – Time For A Change
9. Scientists Awarded Appropriately For Contribution Towards Medical Research
10. A Step Towards Unraveling The Schizophrenia And Depression Mystery
11. Are Women Not Hearty Enough Towards Seeking Heart Care?
Post Your Comments:
(Date:10/6/2008)...ctober 10th, military personnel and their family m...person self-assessments, BOSTON, Oct. 6 /PRNewswi...nges to Service members and their families that ar...are not. In some instances matters get,worse and o...At such times,it is wise to check things out to se...
(Date:10/6/2008)...y led by researchers at the University of Californ... of oral Vitamin D supplements bolsters production...in, and may help prevent skin infections that are ...mon form of eczema. , The study led by Richard ...f of the Division of Dermatology at the UCSD Schoo...
(Date:10/6/2008)...TLE, Oct. 6 /PRNewswire/ -- A special supplement o...tails guidelines for low- and,middle-income countr...and,treat the most common disease among women worl...th and Cancer Control -,Implementation" developed ...ines a tiered system of resource allocation -- bas...
(Date:10/6/2008)...MBUS, Ohio, Oct. 6 /PRNewswire/ -- Ohio,s academic... the state,s economy in 2007, an,increase of appro... major,job generator, employing one in 12 Ohioans,...hio Council of Medical Deans., Quantifying academ...m,tax revenue to job creation, the report undersco...
Breaking Medicine News(10 mins):Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 2Health News:Many Military Installations Worldwide Participate in National Depression Screening Day 3Health News:Oral vitamin D may help prevent some skin infections 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 3Health News:Academic Medicine Means Business for Ohio: $37.2 Billion Economic Impact for the State 2
...new method in ultrasound known as "eSie Touch Elas...olutions at the ECR 2007 (European Congress of Rad... this new method, which is an adjunct to regular b...ically relevant differentiation of benign and mali...
...searchers are taking a closer look at a disease wh...reases. Non-Alcoholic Steatohepatitis, more popula...roximately 15% of obese children. Fatty Liver Dise... not life threatening in children, can lead to cir...
...ere is a far greater risk of lethal assault during...o later episodes, warn mental health experts.// ...Dr Olav Nielssen, psychiatrist at St Vincent’s Hos...-authors review homicides committed during psychot...
...rents should be better educated about the risks of...ording to child health researchers.// Results fr...smoke in cars are more likely to suffer respirator... Medical Journal of Australia, Professor Peter Sly...
Other Medicine News:Health News:eSie Touch Elasticity Imaging, and a Promise of Avoiding Breast Biopsies 2Health News:Incidence of Fatty Liver Disease High Among Obese Children 2Health News:Early Psychosis Is Dangerous 2
(Date:10/6/2008)...l Associations Collaborate to Improve Patient Safe... The American College of,Cardiology in collaborati...nd the American Heart Association today released c...for reducing the risk of ulcers and,gastrointestin...,anti-inflammatory drugs (NSAIDs) along with antip...
(Date:10/6/2008)... Calif. and SEATTLE, Oct. 6 /- Comple...on human genome sequencing,company, and the Instit...r,partnership to conduct populationwide human geno...e Genomics will use its proprietary,DNA sequencing...provided by,ISB. Then, once proof-of-concept has b...
(Date:10/6/2008)...6 /- Dendreon Corporation (...onday, October 6, 2008 at 9:00 AM,ET (6:00 AM PT) ...ts IMPACT,(IMmunotherapy for Prostate AdenoCarcino... of PROVENGE(R) (sipuleucel-T), the Company,s inve...treatment of advanced prostate,cancer., Those ...
(Date:10/3/2008)...ober 3 /- Amsterdam Molecul...ield of human gene therapy,announced today that i...Marketing Authorization Application (MAA) for Glyb... seriously debilitating and potentially lethal,dis... clinical studies (22,patients in total) demonstra...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre Symptomatic Detection of Disease 10231 1Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre Symptomatic Detection of Disease 10231 2Biophysical Unveils BiophysicalCheck Health Assessment Program to Aid in Pre Symptomatic Detection of Disease 10231 3Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 1Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 2Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 3Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program 10227 4Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing 2763 1Mark Ostrowski Joins GenVault as Vice President of Sales and Marketing 2763 2Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic 2759 1Arbor Surgical Technologies Announces Series C Financing and Licensing Agreement with Medtronic 2759 2
...ON, N.J.--(BUSINESS WIRE)--Apr 26, 2007 - Columbia... that preliminary,results from the ongoing data an...bo-controlled, double-blind Phase III clinical,tri...revention of,preterm birth in women with a previou...s revealed a possible effect of PROCHIEVE 8%,in de...
... Australia, April 26, 2007 /PRNewswire-FirstCall/ ...mited today,announced preliminary results from its...th metastatic colorectal cancer, where,Alchemia,s ...s,considered to be a cornerstone drug for the trea...eing made at a preliminary stage of,the analysis i...
Other Medicine Technology:Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 2Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 2Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 4Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 5Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 6Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 7
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: